FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

732981002: Actuation (unit of presentation)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498507019 Actuation (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498508012 Actuation en Synonym Active Entire term case insensitive SNOMED CT core module
105633401000001114 actuation en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Actuation Is a Unit of presentation true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely cromoglicate sodium 5 milligram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely cromoglicate sodium 5 milligram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely terbutaline sulfate 500 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely terbutaline sulfate 500 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely beclometasone dipropionate 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely beclometasone dipropionate 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely budesonide 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely indacaterol (as indacaterol maleate) 75 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely indacaterol (as indacaterol maleate) 75 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely ipratropium bromide 40 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely ipratropium bromide 40 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely indacaterol (as indacaterol maleate) 150 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely indacaterol (as indacaterol maleate) 150 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit False Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit False Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit False Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit False Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely cromoglicate sodium 800 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely cromoglicate sodium 800 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely cromoglicate sodium 5 milligram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely cromoglicate sodium 5 milligram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely salbutamol 400 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely salbutamol 400 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely cromoglicate sodium 20 milligram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely cromoglicate sodium 20 milligram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely desmopressin acetate 150 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely desmopressin acetate 150 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely triamcinolone acetonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely triamcinolone acetonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely zolmitriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely zolmitriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely beclometasone dipropionate 84 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 84 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely ketorolac trometamol 15.8 milligram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely ketorolac trometamol 15.8 milligram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely ciclesonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely ciclesonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely lidocaine 10 milligram/1 actuation conventional release oromucosal spray Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely lidocaine 10 milligram/1 actuation conventional release oromucosal spray Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely olopatadine hydrochloride 665 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely olopatadine hydrochloride 665 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely budesonide 200 microgram/1 actuation conventional release solution for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 200 microgram/1 actuation conventional release solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely cyanocobalamin 500 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely cyanocobalamin 500 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely salbutamol (as salbutamol sulfate) 2.5 milligram/1 actuation conventional release solution for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely salbutamol (as salbutamol sulfate) 2.5 milligram/1 actuation conventional release solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely ipratropium bromide 42 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely ipratropium bromide 42 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely prednisolone (as prednisolone metasulfobenzoate sodium) 20 milligram/1 actuation conventional release rectal foam (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely prednisolone (as prednisolone metasulfobenzoate sodium) 20 milligram/1 actuation conventional release rectal foam (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1

Start Page 2 of 3 End


This concept is not in any reference sets

Back to Start